Categories: Artificial IntelligenceAudioCareHealthTechMeasurement
We develop Digital Audio Biomarkers that break through barriers to care while setting new standards of excellence for clinical measurement.
Investors 2
Mentions in press and media 1
| Date | Title | Description |
| 18.09.2026 | NAVER D2SF Invests in AI-Driven Precision Medicine Company ImpriMed | ImpriMed combines ex vivo functional testing with multimodal AI to support personalized cancer treatment decisions and drug development
The investment is part of ImpriMed's $10 million Series A2 bridge round as the company advances U.S. com... |
Reviews 0
